Ultra-Medanine Capsules: Comprehensive Guide for Psoriasis and Vitiligo Treatment

Ultra-Medanine Capsules are a specialized dermatological drug designed to treat severe skin conditions. These capsules contain Methoxsalen (Ammoidin), a potent photosensitizer, and are used in conjunction with UVA (ultraviolet A) light therapy. This article will explore how Ultra-Medanine works, its indications, usage guidelines, and other essential information to ensure safe and effective treatment.

Active Ingredients

Methoxsalen (Ammoidin) is the primary active ingredient in Ultra-Medanine. Here’s how it functions:

• Role: Methoxsalen enhances the skin’s sensitivity to UVA light. When the drug is administered, it travels through the bloodstream to the skin. Exposure to UVA light then causes cellular damage, leading to inflammation. This process is followed by repair, resulting in increased melanin production and thickening of the skin’s outer layer.
• Mechanism: For conditions like psoriasis, Methoxsalen works by damaging the DNA of proliferating skin cells, which reduces their growth.

Indications for Use

Conditions Treated:

• Severe Recalcitrant Psoriasis: A chronic skin condition characterized by red, scaly patches.
• Vitiligo: A skin disorder causing loss of pigment, leading to white patches on the skin.
• Skin Manifestations of Cutaneous T-Cell Lymphoma: A type of cancer affecting the skin.

Benefits:

• Effective Treatment: Provides significant symptom control for conditions resistant to other treatments.
• Enhanced Melanization: Promotes pigmentation in areas affected by vitiligo.

Dosage and Duration of Use

Recommended Dosage:

• Psoriasis Therapy: Take the capsule 1.5 to 2 hours before UVA exposure. The dosage depends on body weight, as outlined below:
  • <30 kg: 10 mg
  • 30-50 kg: 20 mg
  • 51-65 kg: 30 mg
  • 66-80 kg: 40 mg
  • 81-90 kg: 50 mg
  • 91-115 kg: 60 mg
  • >115 kg: 70 mg
• Vitiligo Therapy:
  • Dosage: Two 10 mg capsules taken 2-4 hours before UVA exposure.
  • Exposure: Initial exposure times vary based on skin color. Gradual increases should be based on skin response, and treatments should be on alternate days.

Duration: Follow the prescribed treatment schedule and avoid extending the dosage or frequency without medical consultation.

Warnings and Precautions

Side Effects:

• Common: Nausea, itching (pruritis), mild or temporary redness of the skin (erythema).
• Less Common: Dizziness, headaches, depression, insomnia, nervousness, leg cramps, low blood pressure (hypotension).

Precautions:

• Sun Exposure: Avoid sunbathing 24 hours before and 48 hours after treatment. Use UVA-blocking sunglasses and protective clothing.
• Interactions: Avoid concurrent use with other photosensitizing agents like griseofulvin, coal tar, and phenothiazines.
• Special Populations:
  • Pregnancy: Use only if clearly needed.
  • Nursing Mothers: Exercise caution; consider discontinuing either the drug or breastfeeding.
  • Children: Safety has not been established.

Lens Exposure: Prevent UVA exposure to lenses during treatment to avoid irreversible binding of Methoxsalen.

Price and Product Information

Pricing: Each box of Ultra-Medanine contains 20 capsules and costs approximately 15 EGP (Egyptian Pounds).

Packaging and Availability: Available in a box containing 20 capsules. It is a prescription-only medication and should be purchased from licensed pharmacies.

Conclusion

Ultra-Medanine Capsules offer a targeted approach to managing severe skin conditions through a combination of Methoxsalen and UVA light therapy. Adhering to dosage instructions and precautions is crucial for maximizing benefits and minimizing risks. Always consult with a healthcare professional before starting or adjusting treatment.

Ultra-Medanine Capsule is produced by Memphis Pharmaceutical Industries, an Egyptian company that distributes and exports its products to various countries in Africa and the Middle East.